Navigation Links
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome

NEW YORK, May 22, 2007 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. and Cypress Bioscience, Inc. today announced that preliminary top-line results from a 1,196 patient randomized, three month, double-blind, placebo-controlled pivotal Phase III study demonstrate statistically significant therapeutic effects of milnacipran as a treatment of fibromyalgia syndrome. At this time the companies have only been able to review initial top-line results and further analyses will be completed in the coming weeks to examine the results in greater detail.

Preliminary Study Results

In the study, patients were randomized to receive either 200mg per day of milnacipran (n=396), 100mg per day of milnacipran (n=399) or placebo (n=401). The primary pre-defined endpoints of this trial were composite responder assessments to evaluate either the treatment of the pain associated with fibromyalgia syndrome or the overall treatment of fibromyalgia syndrome. This composite responder analysis approach, which requires a clinically meaningful improvement in multiple domains, captures in one endpoint improvement in numerous symptoms which comprise this syndrome.

The treatment of pain associated with fibromyalgia is assessed by evaluating pain as measured by the Patient Experience Diary (PED), and the overall impression of patient well being as measured by the Patient Global Impression of Change (PGIC) for patients receiving either dose of milnacipran compared to placebo. The difference between active doses and placebo was assessed by a responder analysis with a responder defined as a subject experiencing both a 30% or greater reduction in pain compared to baseline as measured by a visual analog scale (VAS) and a self assessment of his or her condition by the patient of either "much" or "very much" improved compared to baseline.

The broader evaluation of treatment of fibromyalgia syndrome is assessed by evalua
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
6. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:3/27/2015)... Telbec/ - Russell Williams , President of ... the 2015-2016 Quebec Budget, noting the fiscal discipline and ... industry. However, the association is concerned about the decline ... government,s intent to strive for a balanced budget this ... Quebec,s economic development is encouraging," said ...
(Date:3/27/2015)... DIEGO , March 27, 2015   ... company, today announced new data showing that, compared ... TM technology provided highly equivalent interpretations of ... disease, and did so in a fraction of ... the way for more comprehensive genetic analysis in ...
(Date:3/27/2015)... CHINA AID, the 10 th ... and Healthcare, second to none in China,s ... Shanghai New International Expo Center on 22-24 April. ... Encouraging Private Capital to Participate in the Development of ... the Ministry of Civil Affairs of the People,s ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6
... , EXTON, Pa. , Feb. ... its LaunchTrends ®: Feraheme ... the launch of AMAG,s new IV iron product, Feraheme, through the ... provides quantitative information from 50 unique Nephrologists and qualitative information from ...
... DIEGO , Feb. 16 PatientSafe Solutions, Inc., ... today announced the executive management team tasked with executing the ... safety in healthcare.  James M. Sweeney, Chairman and Chief Executive ... successful healthcare product and service companies including Caremark, Bridge Medical ...
Cached Medicine Technology:Use of AMAG's Feraheme is on the Rise with 23% of Nephrologists Reporting Use of the Product 2PatientSafe Solutions, Inc. Announces Management Team 2PatientSafe Solutions, Inc. Announces Management Team 3
(Date:3/28/2015)... 2015 An article in Fortune on ... prove critical to organizations that deal with PCI (Payment ... of data security, is worsening . Using numbers ... every major category out of the twelve measured improved, ... all the craziness that has gone on in the ...
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... surgery experiences re-injury, according to research presented today at ... ) Specialty Day. The study examined the long term ... younger. , “We examined survey data from 242 ... noted lead author Justin P. Roe, MBBS, FRACS, from ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... for patients with Type V AC joint injuries, according ... study, presented today at the American Orthopaedic Society for ... personnel returned to duty faster when surgery was not ... patients, with 7 receiving surgical treatment and 17 receiving ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Lately the ... media regarding recent changes and proposals around the NCAA. ... current and former collegiate student-athletes across a spectrum of ... reflect on common challenges. The special panel consists of ... in sports ranging from football, track and field, baseball, ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 The ... method of sustainable health. After 18 years of research ... including professional UFC contenders, Dr. Jon Petrick is excited ... , Just some of the immediate benefits of this ... vitality, increased levels of strength of the immune system, ...
Breaking Medicine News(10 mins):Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2
... deficits in children and adults.IRVINE, Calif., March 18 ... to correcting learning and attention deficits associated with ... its first U.S. practitioner training course in Los ... open to special needs professionals and educators, parents ...
... advanced age and existing medical conditions may not see any benefit from annual prostate cancer screening tests, according ... Click here for more information. , , ... , , , ... , , , , ...
... could benefit from taking statins, drugs typically used to ... suggest, Johns Hopkins doctors report in a new study. ... prevent subsequent heart attacks and strokes in patients who ... Additionally, statins have been shown to have a protective ...
... Inc. (TSX: MDS; NYSE: MDZ ), a leading ... today announced that shareholders approved the renewal of the Company,s ... Meeting of Shareholders held March 12, 2009 in Toronto. , ... a party who wishes to become the beneficial owner of ...
... 18 Subaru of America, Inc. has donated a ... McDonald House (RMH) of Southern New Jersey, located in ... $26,000, will be used to transport RMH families of ... The vehicle will also be used by RMH staff ...
... again been forced to revise statements made by Pope Benedict ... to Cameroon on March 17, the pope claimed that condom ... the pope,s comments on the Vatican,s Web site altered the ... president of Catholics for Choice, welcomed the change as a ...
Cached Medicine News:Health News:Raviv Method to Offer First U.S. Practitioner Training Course 2Health News:US trial shows no early mortality benefit from annual prostate cancer screening 2Health News:US trial shows no early mortality benefit from annual prostate cancer screening 3Health News:US trial shows no early mortality benefit from annual prostate cancer screening 4Health News:US trial shows no early mortality benefit from annual prostate cancer screening 5Health News:US trial shows no early mortality benefit from annual prostate cancer screening 6Health News:6.5 million more patients might benefit from statins to prevent heart attacks, strokes 2Health News:MDS Announces Renewal of Company's Shareholders Rights Plan 2Health News:Subaru of America Donates New Outback to Aid Ronald McDonald House Families 2Health News:Subaru of America Donates New Outback to Aid Ronald McDonald House Families 3Health News:Pope Not Infallible on Condoms 2
Bx VELOCITY Coronary Stent with HEPACOAT...
Curved Tip, 23 Gauge Inner Cannula, Nylon Connector (Also available wtih straight tip) Overall length 60mm; Stainless steel...
Hook Shaped Tip , Curved to the Left; with 30 cm long silicone tubing with connector; overall length 40mm; stainless steel...
8 mm diameter nylon handpiece; 100 mm handle with grooves for grip; Standard male luer taper fits most cannula hub and female luer taper....
Medicine Products: